Innoviva (INVA) Dividends Paid - Common Growth (3y) (2017 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 1,370.90% |
| Mar 31, 2022 | 833.46% |
| Sep 30, 2021 | 185.65% |
| Jun 30, 2021 | 186.09% |
| Mar 31, 2021 | 724.32% |
| Dec 31, 2020 | 107.54% |
| Jun 30, 2020 | 572.25% |
| Mar 31, 2020 | 517.95% |
| Dec 31, 2019 | 445.34% |
| Jun 30, 2019 | -71.08% |
| Mar 31, 2019 | -77.68% |
| Dec 31, 2018 | 154.07% |
| Sep 30, 2018 | -59.11% |
| Jun 30, 2018 | -69.12% |
| Mar 31, 2018 | -89.03% |
| Dec 31, 2017 | -78.59% |
| Sep 30, 2017 | -26.07% |